Matthew Kalnik Net Worth & Insider Trades
Matthew Kalnik - SVP Strategic Plan. & Bus. Ops, Nabi Biopharmaceuticals
What is Matthew Kalnik's Net Worth?
The current estimated net worth of Nabi Biopharmaceuticals's SVP Strategic Plan. & Bus. Ops, Matthew Kalnik, is estimated to be about $496.09K . Matthew Kalnik owns about 71,050 units of Nabi Biopharmaceuticals common stock. In the last 2 years at Nabi Biopharmaceuticals, Matthew Kalnik has sold an estimated value of $235.47K worth.
What is Matthew Kalnik's Past Insider Trading?
Matthew Kalnik's largest purchase order was 7,654 units , worth over $21.89K on March 4, 2010. Matthew Kalnik's largest sale order was 14,574 units , worth over $68.63K on November 18, 2009. In total, Matthew Kalnik has made about 10 transactions over 2 years of their time at Nabi Biopharmaceuticals. Matthew Kalnik usually trades in April, with the busiest year in 2010. The most recent transaction was a sale order of 6,300 units , worth over $36.53K on April 5, 2011.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Matthew Kalnik
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Matthew Kalnik's' Mailing Address?
- Mailing address is 7620 Old Georgetown Road Bethesda MD 20814 MD
What are Nabi Biopharmaceuticals's Past Insider Trades?
Nabi Biopharmaceuticals's most recent insider trade came on April 9, 2012 by Paul Kessler who sold 5,167 units worth $9.82K . In the last 9 years, insiders at Nabi Biopharmaceuticals have sold an estimated value of $10.72M and bought an estimated value of $9.22M worth of shares. Insider trading is most common in May, with the busiest year in 2004. The most active traders at the company are Jason Aryeh, Director, Raafat Fahim, President, and Thomas McLain, Chairman .
NABI BIOPHARMACEUTICALS Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |